CTRI/2021/09/036783招募中未知
rinary Neutrophil Gelatinase Associated Lipocalin (uNGAL): assessing its role as a biomarker of spontaneous bacterial peritonitis in patients with decompensated cirrhosis and also in the prediction of prognosis.
Taurus Life Sciences Company0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •Diagnosed cases of decompensated cirrhosis of liver with ascites, with a diagnostic paracentesis done at current admission.
排除标准
- •Pre-existing renal disease/CKD, AKI at the time of hospitalization, renal replacement therapy, secondary peritonitis, malignant diseases, prior antibiotic therapy, urinary tract infection
研究者
相似试验
已完成
不适用
Plasma Neutrophil Gelatinase-Associated Lipocalin in ICU patients with acute renal failureICU patients with acute renal failureJPRN-UMIN000006349Osaka University Hospital50
招募中
不适用
Plasma neutrophil gelatinase-associated lipocalin (NGAL) concentration of living liver transplant recipients according to the albumin administration during surgery: prospective, randomized control trialKCT0007760Samsung Medical Center318
招募中
不适用
Serum neutrophil gelatinase associated lipocalin (NGAL) as early predictor of contrast-induced acute kidney injury after cerebral angiographyKCT0004003Seoul National University Bundang Hospital390
招募中
不适用
eutrophil Gelatinase-Associated Lipocalin as an early detector of ischemic tubular injury in patients admitted to a general Intensive Care Unit.Acute renal dysfunctionkidney failure10038430NL-OMON31307Erasmus MC, Universitair Medisch Centrum Rotterdam700
尚未招募
不适用
Serum NGAL IN Patients With Multiple MyelomaMultiple Myeloma(MM)NCT05439538Assiut University60